Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bln - Reuters #usa
- Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bln Reuters
- Bristol Myers to Acquire Karuna, a Neuroscience Drugmaker, for $14 Billion The New York Times
- Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion CNBC
- KRTX Stock Soars And Breaks Out On Bristol Myers' $14 Billion Takeover Investor's Business Daily
- BMS Closes the Year with $14B Karuna Buy to Bolster Neuro Portfolio BioSpace
Sent via IFTTT







Post a Comment